Regular Article
Calretinin and Calretinin-22k Increase Resistance toward Sodium Butyrate-Induced Differentiation in CaCo-2 Colon Adenocarcinoma Cells

https://doi.org/10.1006/excr.2001.5261Get rights and content

Abstract

Calretinin (CR) and the alternatively spliced form calretinin-22k (CR-22k) are members of the EF-hand family of Ca2+-binding proteins (CaBPs). CR is expressed in more than 60% of poorly differentiated human colon tumors and both isoforms are present in several colon carcinoma cell lines (e.g., WiDr). They are absent in normal enterocytes and in well-differentiated adenocarcinoma cell lines such as CaCo-2. Calretinins are thought to act as Ca2+ buffers and to be involved in the regulation of Ca2+-dependent processes. Down-regulation of calretinins in WiDr cells by antisense oligonucleotides leads to growth inhibition and treatment with sodium butyrate (NaBt, an inducer of differentiation) leads to a blockage of the cell cycle and, in parallel, to down-regulation of CR. It has been proposed that CR and/or CR-22k may be involved in maintaining the undifferentiated phenotype of WiDr cells and contributing to the transformation of enterocytes. Expression levels and distribution of CR-22k were investigated in WiDr cells. CR-22k was down-regulated in NaBt-treated cells and the normally cytoplasmic protein was preferentially localized in the nucleus either as a result of translocation or selective nuclear maintenance, a process more pronounced than in the case of CR. To compare functional differences of calretinins, CR-negative Caco-2 cells were stably transfected with cDNAs encoding CR or CR-22k. Cell growth of CR-transfected cells was increased, an effect that was not observed in CR-22k-transfected ones. The CR-expressing clones were almost completely resistant to treatment with 0.5 mM NaBt, a concentration significantly reducing cell growth in control cells. The same effect was obtained in the CR-22k-expressing clones, although to a lesser extent. This implicates that expression of CR and/or CR-22k in colon tumor cells may contribute to tumorigenesis by blocking differentiation-promoting signals.

References (66)

  • D. Marilley et al.

    Association between the calcium-binding protein calretinin and cytoskeletal components in the human colon adenocarcinoma cell line WiDr

    Exp. Cell Res.

    (2000)
  • V. Gotzos et al.

    Expression of the calcium binding protein calretinin in WiDr cells and its correlation to their cell cycle

    Exp. Cell Res.

    (1992)
  • J.-C. Gander et al.

    The calcium-binding protein calretinin-22k, an alternative splicing product of the calretinin gene is expressed in several colon adenocarcinoma cell lines

    Cell Calcium

    (1996)
  • B. Schwaller et al.

    Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin

    Cell Calcium

    (1993)
  • C. Andressen et al.

    Changes in shape and motility of cells transfected with parvalbumin cDNA

    Exp. Cell Res.

    (1995)
  • P. Chomczynski et al.

    Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

    Anal. Biochem.

    (1987)
  • K. Nakano et al.

    Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line

    J. Biol. Chem.

    (1997)
  • A. Souleimani et al.

    Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2

    FEBS Lett.

    (1993)
  • S. Archer et al.

    Butyrate inhibits colon carcinoma cell growth through two distinct pathways

    Surgery

    (1998)
  • M.J. Hubbard et al.

    Calbindin 28kDa and calbindin 30kDa (calretinin) are substantially localised in the particulate fraction of rat brain

    FEBS Lett.

    (1995)
  • B. Schwaller et al.

    Comparison of the Ca2+-binding properties of human recombinant calretinin-22k and calretinin

    J. Biol. Chem.

    (1997)
  • D. Plogmann et al.

    Intracellular concentration of parvalbumin in nerve cells

    Brain Res.

    (1993)
  • N. Agell et al.

    New nuclear functions for calmodulin

    Cell Calcium

    (1998)
  • S. Hermann et al.

    Calcium regulation of basic helix–loop–helix transcription factors

    Cell Calcium

    (1998)
  • J. Onions et al.

    Basic helix–loop protein sequences determining differential inhibition by calmodulin and S-100 proteins

    J. Biol. Chem.

    (1997)
  • A.W. Burgess

    Growth control mechanisms in normal and transformed intestinal cells

    Philos. Trans. R. Soc. Lond. B Biol. Sci.

    (1998)
  • J.I. Gordon et al.

    Studies of intestinal stem cells using normal, chimeric, and transgenic mice

    FASEB J.

    (1992)
  • N.A. Wright et al.

    The kinetics of villus cell populations in the mouse small intestine. I. Normal villi: The steady state requirement

    Cell Tissue Kinet.

    (1982)
  • J.F. Whitfield et al.

    Calcium-cell cycle regulator, differentiator, killer, chemopreventor, and maybe, tumor promoter

    J. Cell. Biochem. Suppl.

    (1995)
  • D.A. Litvak et al.

    Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1

    Surgery

    (1998)
  • D.P. Burkitt

    Epidemiology of cancer of the colon and rectum

    Cancer

    (1971)
  • P.R. Gibson et al.

    Colonic epithelial cell activation and the paradoxical effects of butyrate

    Carcinogenesis

    (1999)

    • Cited by (0)

    1

    To whom correspondence and reprint requests should be addressed at Institute of Histology and General Embryology, Pérolles, CH-1705 Fribourg, Switzerland. Fax: +41 26 300 9732. E-mail: [email protected].

    View full text
    Copyright © 2001 Academic Press. All rights reserved.